AFJK Aimei Health Technology Co., Ltd - Ordinary Share
$41.50
Price · May 20, 2026
Fundamentals as of Nov 18, 2025
52W Range
$7–$130
28% of range
Analyst Rating
—
Price Target
—
P/E (TTM)
—
ROE
-224.5%
Net Profit Margin
—
AFJK Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$41.50
Market Cap
$23M
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
-224.5%
Debt/Equity
—
52W Range
$7 – $130
AFJK Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
AFJK
Peer Median
P/B
-15.4
0.9
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
AFJK
Peer Median
ROA
3.5%
3.1%
ROE
-224.5%
3.9%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
AFJK
Peer Median
Current Ratio
0.0
1.8
Quick Ratio
0.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
AFJK
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
AFJK
Peer Median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Next Report
Jun 01, 2026
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 5
| Metric | Trend | 2024 |
|---|---|---|
| Operating Income | $-1M | |
| Other Non-op | $4M | |
| Income Tax | $0 | |
| Net Income | $3M | |
| EBITDA | $-1M |
Balance Sheet 12
| Metric | Trend | 2024 |
|---|---|---|
| Cash & Equivalents | $28.2K | |
| Prepaid Expense | $2.2K | |
| Current Assets | $30.4K | |
| Total Assets | $74M | |
| Accrued Liabilities | $299.5K | |
| Current Liabilities | $817.0K | |
| Total Liabilities | $2M | |
| Common Stock | $213 | |
| Retained Earnings | $-1M | |
| Stockholders' Equity | $-1M | |
| Liabilities + Equity | $74M | |
| Shares Outstanding | 2,126,000 |
Cash Flow 4
| Metric | Trend | 2024 |
|---|---|---|
| Operating Cash Flow | $-672.3K | |
| Investing Cash Flow | $-277.7K | |
| Financing Cash Flow | $397.5K | |
| Net Change in Cash | $-552.5K |
Profitability 2
| Metric | Trend | 2024 |
|---|---|---|
| ROA | 3.5% | |
| ROE | -224.5% |
Liquidity & Solvency 2
| Metric | Trend | 2024 |
|---|---|---|
| Current Ratio | 0.0 | |
| Quick Ratio | 0.0 |
Valuation (TTM) 4
| Metric | Trend | 2024 |
|---|---|---|
| Net Income TTM | $3M | |
| Market Cap | $23M | |
| P/B | -15.4 | |
| P / Cash Flow | -33.8 |
Income Statement 5
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Operating Income | $-130.2K | $-41.6K | $-413.4K | $-200.0K | $-309.1K | $-153.6K | |
| Other Non-op | $482.2K | $466.6K | $598.1K | $943.5K | $918.2K | $909.1K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $352.0K | $425.0K | $184.7K | $743.5K | $609.1K | $755.5K | |
| EBITDA | $-130.2K | $-41.6K | $-413.4K | · | · | · |
Balance Sheet 12
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.0K | $2.1K | $7.3K | $103.6K | $157.5K | $413.7K | |
| Prepaid Expense | $22.0K | $42.5K | $677 | $20.3K | $46.8K | $66.7K | |
| Current Assets | $24.9K | $44.6K | $8.0K | $123.9K | $204.3K | $480.7K | |
| Total Assets | $45M | $45M | $44M | $73M | $72M | $71M | |
| Accrued Liabilities | $292.6K | $309.1K | $457.4K | $142.0K | $59.4K | $78.5K | |
| Current Liabilities | $3M | $2M | $2M | $230.8K | $111.2K | $78.5K | |
| Total Liabilities | $3M | $3M | $2M | $920.8K | $801.2K | $768.5K | |
| Common Stock | $213 | $213 | $213 | $213 | $213 | $213 | |
| Retained Earnings | $-3M | $-3M | $-2M | $-797.1K | $-597.1K | $-288.0K | |
| Stockholders' Equity | $-3M | $-3M | $-2M | $-796.9K | $-596.9K | $-287.8K | |
| Liabilities + Equity | $45M | $45M | $44M | $73M | $72M | $71M | |
| Shares Outstanding | 2,126,000 | 2,126,000 | 2,126,000 | 2,126,000 | 2,126,000 | 2,126,000 |
Cash Flow 4
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-96.1K | $-201.8K | $-224.0K | $-53.9K | $-256.2K | $-167.0K | |
| Investing Cash Flow | $-450.0K | $-450.0K | $31M | · | · | · | |
| Financing Cash Flow | $547.0K | $646.5K | $-31M | · | · | · | |
| Net Change in Cash | $841 | $-5.2K | $-20.9K | $-53.9K | $-256.2K | $-167.0K |
Profitability 2
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| ROA | 0.60% | 0.73% | 0.32% | 2.0% | 1.7% | 2.1% | |
| ROE | -16.6% | -24.6% | -13.9% | -186.6% | -204.1% | -525.1% |
Liquidity & Solvency 2
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.0 | 0.0 | 0.0 | 0.5 | 1.8 | 6.1 | |
| Quick Ratio | 0.0 | 0.0 | 0.0 | 0.4 | 1.4 | 5.3 |
Valuation (TTM) 4
| Metric | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $2M | $2M | $2M | · | $1M | · | |
| Market Cap | $24M | $24M | $23M | $22M | $22M | $22M | |
| P/B | -7.0 | -8.3 | -9.9 | -28.0 | -36.9 | -75.8 | |
| P / Cash Flow | · | · | -104.4 | · | · | -130.6 |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2024-12-31 | 2023-12-31 | |
|---|---|---|
| Net Income | $3M | — |
Balance Sheet
| 2024-12-31 | 2023-12-31 | |
|---|---|---|
| Current Ratio | 0.0 | 23.4 |
| Quick Ratio | 0.0 | 23.4 |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.